Rocketing sales, reduced costs shrink AFT Pharmaceuticals’ loss
AFT Pharmaceuticals reports reduced losses in latest results.
Thu, 22 Nov 2018
AFT Pharmaceuticals' sales have doubled and its first half-year loss has shrunk compared to the same period last year.
The New Zealand company, which manufactures the painkiller Maxigesic, reported losses of $109,000 for the six months to September 2018. The first-half loss is down from -$6.7
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
